Interpretable statistical models for multivariate vaccine induced immune response data are important as they provide a rigorous means of deciding which vaccine candidates should be advanced in the clinical trials process. We consider applications of several different statistical models to a vaccine data set which contains multivariate immune responses for several novel Tuberculosis vaccines and the current BCG vaccine. The immune responses in the data set have several features which the models need to account for. In particular, the models need to account for the multivariate repeated measures for the subjects, the nonlinear profiles of the immune responses, and the zero-inflated skew distributions of the immune responses. We find that Twee...
Eradication of tuberculosis (TB), the world's leading cause of death due to infectious disease, requ...
Vaccines have received a great deal of attention recently as potential therapies in cancer clinical ...
Specific methodological challenges exist in vaccine clinical trials, due principally to specificitie...
BACKGROUND: Vaccine clinical studies typically provide time-resolved data on adaptive response read-...
International audienceEvaluation of immunogenicity is a key step in the clinical development of nove...
Clinical trials covering the immunogenicity of a vaccine aim to study the longitudinal dynamics of c...
Tuberculosis (TB), caused by the pathogen Mycobacterium tuberculosis (M.tb), is the leading cause of...
Les essais cliniques de vaccins posent des défis méthodologiques particuliers, principalement liés à...
Thesis (Ph.D.)--University of Washington, 2023In vaccine research, it is important to identify bioma...
INTRODUCTION: There are Challenges in statistically modelling immune responses to longitudinal HIV v...
Experimental infection (EI) studies, involving the intentional inoculation of animal or human subjec...
grantor: University of TorontoUsing epidemic simulations in randomly mixing and stratifie...
Analysis of the occurrence of adverse events, and in particular of solicited symptoms, following vac...
Abstract Background Immuno-epidemiologists are often faced with multivariate outcomes, measured repe...
Evaluation of immunogenicity is a key step in the clinical development of novel vaccines. T-cell res...
Eradication of tuberculosis (TB), the world's leading cause of death due to infectious disease, requ...
Vaccines have received a great deal of attention recently as potential therapies in cancer clinical ...
Specific methodological challenges exist in vaccine clinical trials, due principally to specificitie...
BACKGROUND: Vaccine clinical studies typically provide time-resolved data on adaptive response read-...
International audienceEvaluation of immunogenicity is a key step in the clinical development of nove...
Clinical trials covering the immunogenicity of a vaccine aim to study the longitudinal dynamics of c...
Tuberculosis (TB), caused by the pathogen Mycobacterium tuberculosis (M.tb), is the leading cause of...
Les essais cliniques de vaccins posent des défis méthodologiques particuliers, principalement liés à...
Thesis (Ph.D.)--University of Washington, 2023In vaccine research, it is important to identify bioma...
INTRODUCTION: There are Challenges in statistically modelling immune responses to longitudinal HIV v...
Experimental infection (EI) studies, involving the intentional inoculation of animal or human subjec...
grantor: University of TorontoUsing epidemic simulations in randomly mixing and stratifie...
Analysis of the occurrence of adverse events, and in particular of solicited symptoms, following vac...
Abstract Background Immuno-epidemiologists are often faced with multivariate outcomes, measured repe...
Evaluation of immunogenicity is a key step in the clinical development of novel vaccines. T-cell res...
Eradication of tuberculosis (TB), the world's leading cause of death due to infectious disease, requ...
Vaccines have received a great deal of attention recently as potential therapies in cancer clinical ...
Specific methodological challenges exist in vaccine clinical trials, due principally to specificitie...